Aspaveli, Infusionslösung

7680686740020 CH-68674 Infusionslösung
Aspaveli, Infusionslösung
Aspaveli, Infusionslösung
Aspaveli, Infusionslösung
1 / 3
google

Article details

Package size
8
Selling units
8
Measure
Durchstechflasche(n)
Galenic form
Infusionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/07/2025
Patient information leaflet
Français
18/07/2025
Patient information leaflet
Italien
18/07/2025
Summary of Product Characteristics
Allemand
17/07/2025
Summary of Product Characteristics
Français
17/07/2025
Summary of Product Characteristics
Italien
17/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
54.0 MG Substance Wirkstoff (Principe actif)
(N/A)
41.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.37 MG Substance HBESI

Reimbursement information

Public price
CHF 23485.55
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2023

Authorization holder

Swedish Orphan Biovitrum AG

4058 Basel

Authorization information

Swissmedic authorization number
68674
Drug name
Aspaveli, Infusionslösung
Galenic form
LSINF
ATC Code
L04AJ03
Authorization status
Z
Dispensing category
A
First authorization
23/03/2023
Authorization expiration date
22/03/2028
IT Number
07.15.0.
Domain
Human medicine
Field of application
als Monotherapie für die Behandlung erwachsener Patienten mit paroxysmaler nächtlicher Hämoglobinurie (PNH), welche eine hämolytische Anämie aufweisen.

Package details

Description (FR)
ASPAVELI sol perf 1080 mg/20ml 8 flac 20 ml
Description (DE)
ASPAVELI Inf Lös 1080 mg/20ml 8 Durchstf 20 ml
Market launch
23/03/2023
Narcotic (BTM)
No

Other package sizes (1)

ASPAVELI sol perf 1080 mg/20ml flac 20 ml
1 DUR
GTIN: 7680686740013
View